Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease; First clinical study of a rationally-defined bacterial consortium for an immune-mediated disease; Miles

Press/Media

Period27 Nov 2018

Media coverage

1

Media coverage

  • TitleVedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease; First clinical study of a rationally-defined bacterial consortium for an immune-mediated disease; Miles
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date27/11/18
    PersonsJeremiah Faith